journal cover

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA

Annals of the Rheumatic Diseases

May 7, 2013

Jakub ZávadaBritish Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium

Abstract

To evaluate the risk of gastrointestinal perforation (GIP) in subjects with rheumatoid arthritis (RA) treated with antitumour necrosis factor (anti-TNF) therapy compared with non-biological disease-modifying antirheumatic drugs (nbDMARDs). Using data from the British Society for Rheumat...read more

Mentioned in this Paper

Necrosis
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Biological Products
Intestinal Perforation
Gastrointestinal Diseases
Rheumatoid Arthritis
Gastrointestinal Perforation
Stomach Diseases
Steroids
11
35
Paper Details
References
  • References11
  • Citations7
12
  • References11
  • Citations7
1

Similar Papers Found In These Feeds

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Related Papers

Annals of the Rheumatic Diseases

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

Annals of the Rheumatic DiseasesJuly 26, 2011
Rebecca DaviesBSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register
© 2020 Meta ULC. All rights reserved

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA

Annals of the Rheumatic Diseases

May 7, 2013

Jakub ZávadaBritish Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium

PMID: 23644671

DOI: 10.1136/annrheumdis-2012-203102

Abstract

To evaluate the risk of gastrointestinal perforation (GIP) in subjects with rheumatoid arthritis (RA) treated with antitumour necrosis factor (anti-TNF) therapy compared with non-biological disease-modifying antirheumatic drugs (nbDMARDs). Using data from the British Society for Rheumat...read more

Mentioned in this Paper

Necrosis
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Biological Products
Intestinal Perforation
Gastrointestinal Diseases
Rheumatoid Arthritis
Gastrointestinal Perforation
Stomach Diseases
Steroids
11
35

Similar Papers Found In These Feeds

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Related Papers

Annals of the Rheumatic Diseases

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

Annals of the Rheumatic DiseasesJuly 26, 2011
Rebecca DaviesBSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register
Paper Details
References
  • References11
  • Citations7
12
  • References11
  • Citations7
1
/papers/the-risk-of-gastrointestinal-perforations-in/23644671